All type of patients: 7 trials - ESSENCE - TIMI 11 B (short term) - SYNERGY - INTERACT - EVET - TIMI 11 B (long term) - RESCUE
| enoxaparin vs tinzaparin | No demonstrated result suggested death, myocardial infarction, or recurrent at 30 days by 37% (not demonstrated) | |
| enoxaparin vs UFH (on top of aspirin) | No demonstrated result Minor bleeding by 40% (harmful effect) Major bleeding by 15% (harmful effect) suggested death, myocardial infarction, or recurrent at 30 days by 17% (not demonstrated) suggested recurrent angina by 19% (not demonstrated) suggested myocardial infarction (fatal and non fatal) by 12% (not demonstrated) suggested Revascularization by 14% (not demonstrated) | |
| enoxaparin vs unfractionated heparin | No demonstrated result |
All type of patients: 6 trials - ASSENT 3 - HART II - Baird - ENTIRE-TIMI 2 - ASSENT 3 Plus - AMI-SK
| Enoxaparin vs placebo | No demonstrated result suggested reinfarction by 66% (not demonstrated) suggested reinfarction at 30 days by 68% (not demonstrated) | |
| Enoxaparin vs UFH | No demonstrated result suggested reinfarction by 39% (not demonstrated) suggested reinfarction at 30 days by 36% (not demonstrated) |
Patients hospitalized for heart failure: 1 trials - THE-PRINCE (Kleber)
| enoxaparin vs UFH | No demonstrated result |
All type of patients: 10 trials - STEEPLE - Rabah - CRUISE - Galeote - Dudek - Dudek b (enox alone) - Drozd - Dubek b (+abciximal) - STREAM - ATOLL
| enoxaparin vs UFH | No demonstrated result | |
| enoxaparin vs unfractionated heparin | No demonstrated result | |
| enoxaparin+abciximab vs UFH | No demonstrated result |
All type of patients: 2 trials - PREPIC - Merli sub group
| Enoxaparin vs unfractionated heparin | No demonstrated result |
Superficial thrombophlebitis of the leg : 2 trials - Stenox (enoxaparin 40mg) - STENOX (enoxaparin 1.5mg/hg)
| enoxaparin vs placebo | No demonstrated result |
Abdominal surgery: 2 trials - McLeod (Canadian) - Gonzalez
| enoxaparin vs unfractionated heparin | No demonstrated result |
All type of patients: 9 trials - Simonneau et al - Merli - Merli (once daily vs UFH) - Pini - Gonzalez-Fajardo - Veiga - Meyer - Deitcher - González-Fajardo
| Enoxaparin vs acenocoumarol | No demonstrated result | |
| Enoxaparin vs coumarin | No demonstrated result suggested VTE during active anticoagulant treatment by 97% (not demonstrated) | |
| Enoxaparin vs unfractionated heparin | No demonstrated result | |
| Enoxaparin vs warfarin | No demonstrated result | |
| once daily enoxaparin vs twice daily enoxaparin | No demonstrated result | |
| once daily enoxaparin vs UFH | No demonstrated result |
-
About
-
Browse pathology
|
treatment
-
Site map
-
Credits
Made with in Lyon
-
Contact us
-
Privacy policy
-
